TAYLOR MORRISON HOME CORP (TMHC) Fundamental Analysis & Valuation

NYSE:TMHC • US87724P1066

Current stock price

62.96 USD
-0.28 (-0.44%)
At close:
62.96 USD
0 (0%)
After Hours:

This TMHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. TMHC Profitability Analysis

1.1 Basic Checks

  • TMHC had positive earnings in the past year.
  • In the past year TMHC had a positive cash flow from operations.
  • Each year in the past 5 years TMHC has been profitable.
  • Each year in the past 5 years TMHC had a positive operating cash flow.
TMHC Yearly Net Income VS EBIT VS OCF VS FCFTMHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

1.2 Ratios

  • TMHC's Return On Assets of 6.83% is fine compared to the rest of the industry. TMHC outperforms 75.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 10.70%, TMHC is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 8.54%, TMHC is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • TMHC had an Average Return On Invested Capital over the past 3 years of 10.70%. This is in line with the industry average of 8.88%.
Industry RankSector Rank
ROA 6.83%
ROE 10.7%
ROIC 8.54%
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.99%
ROE(5y)16.32%
ROIC(3y)10.7%
ROIC(5y)11.15%
TMHC Yearly ROA, ROE, ROICTMHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • TMHC has a better Profit Margin (8.77%) than 80.00% of its industry peers.
  • In the last couple of years the Profit Margin of TMHC has grown nicely.
  • TMHC has a Operating Margin of 12.86%. This is amongst the best in the industry. TMHC outperforms 81.67% of its industry peers.
  • TMHC's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 22.59%, TMHC is doing worse than 63.33% of the companies in the same industry.
  • In the last couple of years the Gross Margin of TMHC has grown nicely.
Industry RankSector Rank
OM 12.86%
PM (TTM) 8.77%
GM 22.59%
OM growth 3Y-6.43%
OM growth 5Y13.93%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
TMHC Yearly Profit, Operating, Gross MarginsTMHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TMHC Health Analysis

2.1 Basic Checks

  • TMHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, TMHC has less shares outstanding
  • The number of shares outstanding for TMHC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, TMHC has a worse debt to assets ratio.
TMHC Yearly Shares OutstandingTMHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TMHC Yearly Total Debt VS Total AssetsTMHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • TMHC has an Altman-Z score of 3.64. This indicates that TMHC is financially healthy and has little risk of bankruptcy at the moment.
  • TMHC's Altman-Z score of 3.64 is in line compared to the rest of the industry. TMHC outperforms 60.00% of its industry peers.
  • The Debt to FCF ratio of TMHC is 3.40, which is a good value as it means it would take TMHC, 3.40 years of fcf income to pay off all of its debts.
  • TMHC has a Debt to FCF ratio (3.40) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.38 indicates that TMHC is not too dependend on debt financing.
  • TMHC has a Debt to Equity ratio of 0.38. This is comparable to the rest of the industry: TMHC outperforms 41.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 3.4
Altman-Z 3.64
ROIC/WACC0.91
WACC9.35%
TMHC Yearly LT Debt VS Equity VS FCFTMHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 7.00 indicates that TMHC has no problem at all paying its short term obligations.
  • The Current ratio of TMHC (7.00) is better than 80.00% of its industry peers.
  • A Quick Ratio of 0.90 indicates that TMHC may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.90, TMHC is in line with its industry, outperforming 43.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7
Quick Ratio 0.9
TMHC Yearly Current Assets VS Current LiabilitesTMHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. TMHC Growth Analysis

3.1 Past

  • The earnings per share for TMHC have decreased strongly by -21.81% in the last year.
  • Measured over the past years, TMHC shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.33% on average per year.
  • TMHC shows a decrease in Revenue. In the last year, the revenue decreased by -8.99%.
  • TMHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.79% yearly.
EPS 1Y (TTM)-21.81%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-45.89%
Revenue 1Y (TTM)-8.99%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-24.21%

3.2 Future

  • The Earnings Per Share is expected to decrease by -7.38% on average over the next years.
  • Based on estimates for the next years, TMHC will show a decrease in Revenue. The Revenue will decrease by -4.12% on average per year.
EPS Next Y-31.59%
EPS Next 2Y-7.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.63%
Revenue Next 2Y-4.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TMHC Yearly Revenue VS EstimatesTMHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
TMHC Yearly EPS VS EstimatesTMHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

7

4. TMHC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.25, the valuation of TMHC can be described as reasonable.
  • Based on the Price/Earnings ratio, TMHC is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
  • TMHC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.35.
  • The Price/Forward Earnings ratio is 9.46, which indicates a very decent valuation of TMHC.
  • Based on the Price/Forward Earnings ratio, TMHC is valued cheaply inside the industry as 81.67% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.23, TMHC is valued rather cheaply.
Industry RankSector Rank
PE 9.25
Fwd PE 9.46
TMHC Price Earnings VS Forward Price EarningsTMHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TMHC is valued a bit cheaper than the industry average as 68.33% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, TMHC is valued cheaply inside the industry as 81.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.67
EV/EBITDA 7.52
TMHC Per share dataTMHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • TMHC has a very decent profitability rating, which may justify a higher PE ratio.
  • TMHC's earnings are expected to decrease with -7.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.4
EPS Next 2Y-7.38%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TMHC Dividend Analysis

5.1 Amount

  • No dividends for TMHC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TMHC Fundamentals: All Metrics, Ratios and Statistics

TAYLOR MORRISON HOME CORP

NYSE:TMHC (4/27/2026, 8:04:00 PM)

After market: 62.96 0 (0%)

62.96

-0.28 (-0.44%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)04-22
Earnings (Next)07-21
Inst Owners101.83%
Inst Owner Change1.69%
Ins Owners0.59%
Ins Owner Change13.67%
Market Cap5.96B
Revenue(TTM)7.61B
Net Income(TTM)667.66M
Analysts78.82
Price Target74.06 (17.63%)
Short Float %5.46%
Short Ratio4.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.44%
Min EPS beat(2)-1.84%
Max EPS beat(2)28.73%
EPS beat(4)2
Avg EPS beat(4)6.26%
Min EPS beat(4)-2.85%
Max EPS beat(4)28.73%
EPS beat(8)5
Avg EPS beat(8)5.23%
EPS beat(12)7
Avg EPS beat(12)5.09%
EPS beat(16)10
Avg EPS beat(16)7.06%
Revenue beat(2)1
Avg Revenue beat(2)0.54%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)1.32%
Revenue beat(4)2
Avg Revenue beat(4)0.82%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)4.54%
Revenue beat(8)6
Avg Revenue beat(8)1.31%
Revenue beat(12)9
Avg Revenue beat(12)2.67%
Revenue beat(16)12
Avg Revenue beat(16)2.24%
PT rev (1m)-4.22%
PT rev (3m)-3.83%
EPS NQ rev (1m)-2.07%
EPS NQ rev (3m)-21%
EPS NY rev (1m)0.47%
EPS NY rev (3m)-19.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.99%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-5.55%
Valuation
Industry RankSector Rank
PE 9.25
Fwd PE 9.46
P/S 0.78
P/FCF 8.67
P/OCF 8.17
P/B 0.96
P/tB 1.07
EV/EBITDA 7.52
EPS(TTM)6.81
EY10.82%
EPS(NY)6.66
Fwd EY10.57%
FCF(TTM)7.26
FCFY11.53%
OCF(TTM)7.7
OCFY12.23%
SpS80.35
BVpS65.86
TBVpS58.86
PEG (NY)N/A
PEG (5Y)0.4
Graham Number100.458 (59.56%)
Profitability
Industry RankSector Rank
ROA 6.83%
ROE 10.7%
ROCE 11.19%
ROIC 8.54%
ROICexc 9.23%
ROICexgc 10.05%
OM 12.86%
PM (TTM) 8.77%
GM 22.59%
FCFM 9.04%
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.99%
ROE(5y)16.32%
ROIC(3y)10.7%
ROIC(5y)11.15%
ROICexc(3y)11.72%
ROICexc(5y)12.31%
ROICexgc(3y)13.58%
ROICexgc(5y)14.24%
ROCE(3y)14.02%
ROCE(5y)14.61%
ROICexgc growth 3Y-12.31%
ROICexgc growth 5Y15.36%
ROICexc growth 3Y-12.76%
ROICexc growth 5Y14.64%
OM growth 3Y-6.43%
OM growth 5Y13.93%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
F-Score5
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 3.4
Debt/EBITDA 2.29
Cap/Depr 99.82%
Cap/Sales 0.55%
Interest Coverage 250
Cash Conversion 71.47%
Profit Quality 103.03%
Current Ratio 7
Quick Ratio 0.9
Altman-Z 3.64
F-Score5
WACC9.35%
ROIC/WACC0.91
Cap/Depr(3y)96.24%
Cap/Depr(5y)86.45%
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.41%
Profit Quality(3y)73.15%
Profit Quality(5y)75.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.81%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-45.89%
EPS Next Y-31.59%
EPS Next 2Y-7.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.99%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-24.21%
Revenue Next Year-15.63%
Revenue Next 2Y-4.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.99%
EBIT growth 3Y-6.83%
EBIT growth 5Y20.52%
EBIT Next Year-28.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y129.83%
FCF growth 3Y-10.32%
FCF growth 5Y-6.47%
OCF growth 1Y122.44%
OCF growth 3Y-9.64%
OCF growth 5Y-6.16%

TAYLOR MORRISON HOME CORP / TMHC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TAYLOR MORRISON HOME CORP (TMHC) stock?

ChartMill assigns a fundamental rating of 5 / 10 to TMHC.


What is the valuation status for TMHC stock?

ChartMill assigns a valuation rating of 7 / 10 to TAYLOR MORRISON HOME CORP (TMHC). This can be considered as Undervalued.


Can you provide the profitability details for TAYLOR MORRISON HOME CORP?

TAYLOR MORRISON HOME CORP (TMHC) has a profitability rating of 7 / 10.


Can you provide the financial health for TMHC stock?

The financial health rating of TAYLOR MORRISON HOME CORP (TMHC) is 5 / 10.